Same Indication

Montelukast vs Rabeprazole

Montelukast vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Montelukast and Rabeprazole.

Mechanism of Action

Montelukast: Selective leukotriene D4 receptor antagonist.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Montelukast — 2.7-5.5 hours; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Montelukast — C35H36ClNO3S; Rabeprazole — C18H21N3O3S.

Molecular Weight: Montelukast — 586.1800 g/mol; Rabeprazole — 359.4440 g/mol.

Type: Montelukast — Small molecule; Rabeprazole — Small molecule.